Reduced Synaptic Density in Patients with Lewy Body Dementia: An [ 11 C ] UCB‐J PET Imaging Study
Open accessAbstract
Background: Patients with Parkinson's disease (PD) often develop dementia, but the underlying substrate is incompletely understood. Generalized synaptic degeneration may contribute to dysfunction and cognitive decline in Lewy body dementias, but in vivo evidence is lacking. Objective: The objective of this study was to assess the density of synapses in non‐demented PD (nPD) subjects (N = 21), patients with PD‐dementia or Dementia with Lewy bodies (DLB) (N = 13), and age‐matched healthy controls (N = 15). Method: Using in vivo PET imaging and the novel synaptic‐vesicle‐glycoprotein 2A (SV2A) radioligand [11C]UCB‐J, SUVR‐1 values were obtained for 12 pre‐defined regions. Volumes‐of‐interest were defined on MRI T1 scans. Voxel‐level between‐group comparisons of [11C]UCB‐J SUVR‐1 were performed. All subjects underwent neuropsychological assessment. Correlations between [11C]UCB‐ J PET and domain‐specific cognitive functioning were examined. Results: nPD patients only demonstrated significantly reduced SUVR‐1 values in the substantia nigra (SN) compared to HC. DLB/PDD patients demonstrated reduced SUVR‐1 values in SN and all cortical VOIs except for the hippocampus and amygdala. The voxel‐based analysis supported the VOI results. Significant correlation was seen between middle frontal gyrus [11C]UCB‐J SUVR‐1 and performance on tests of executive function. Conclusion: Widespread cortical reduction of synaptic density was documented in a cohort of DLB/PDD subjects using in vivo [11C]UCB‐J PET. Our study confirms previously reported synaptic loss in SN of nPD patients. [11C]UCB‐J binding in selected cortical VOIs of the DLB/PDD patients correlated with their levels of cognitive function across relevant neuropsychological domains. These findings suggest that the loss of synaptic density contributes to cognitive impairment in nPD and DLB/PDD. © 2021 International Parkinson and Movement Disorder Society
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Severe synaptic loss has been observed using 11C-UCBJ PET in series of cases with DLB, FTD, PD, PDD, PSP, CBD, and C9Orf72 mutation carriers.
“while severe synaptic loss has been observed using 11C -UCBJ PET in series of cases with DLB, FTD, PD, PDD, PSP, CBD and C9Orf72 mutation carriers [205–209].”
From The use of neuroimaging techniques in the early and differential diagnosis of dementia (2023) · cites this paper as [205]
Cites
MDS clinical diagnostic criteria for Parkinson’s disease
Postuma, R. B., Berg, D., Stern, M., Poewe, W., Olanow, C. W., Oertel, W., Obeso, J., Marek, K., Litvan, I., Lang, A. E., et al. (2015) · Movement Disorders · doi:10.1002/mds.26424 · Cited by 7,653 · see citing works
Nabulsi, N. B., Mercier, J., Holden, D., Carré, S., Najafzadeh, S., Vandergeten, M.-C., Lin, S.-F., Deo, A., Price, N., Wood, M., et al. (2016) · Journal of Nuclear Medicine · doi:10.2967/jnumed.115.168179 · Cited by 296 · see citing works
Synaptic proteins predict cognitive decline in Alzheimer's disease and Lewy body dementia
Bereczki, E., Francis, P. T., Howlett, D., Pereira, J. B., Höglund, K., Bogstedt, A., Cedazo‐Minguez, A., Baek, J., Hortobágyi, T., Attems, J., et al. (2016) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2016.04.005 · Cited by 167 · see citing works
11C-UCB-J synaptic PET and multimodal imaging in dementia with Lewy bodies
Nicastro, N., Holland, N., Savulich, G., Carter, S. F., Mak, E., Hong, Y. T., Milicevic Sephton, S., Fryer, T. D., Aigbirhio, F. I., Rowe, J. B., et al. (2020) · European Journal of Hybrid Imaging · doi:10.1186/s41824-020-00093-9 · Cited by 28 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
The use of neuroimaging techniques in the early and differential diagnosis of dementia
Chouliaras, L., & O’Brien, J. T. (2023) · Molecular Psychiatry · doi:10.1038/s41380-023-02215-8 · Cited by 186 · see citing works
“…early AD and 19 controls con fi rmed reduction of 11 C-UCBJ PET binding in medial temporal and neocortical brain regions in early AD [204] while severe synaptic loss has been observed using 11 C -UCBJ PET in series of cases with DLB, FTD, PD, PDD, PSP, CBD and C9Orf72 mutation carriers [205 – 209].”
MethodSynaptic Vesicle Glycoprotein 2A: Features and Functions
Rossi, R., Arjmand, S., Bærentzen, S. L., Gjedde, A., & Landau, A. M. (2022) · Frontiers in Neuroscience · doi:10.3389/fnins.2022.864514 · Cited by 123 · see citing works
Imaging of Synaptic Density in Neurodegenerative Disorders
Carson, R. E., Naganawa, M., Toyonaga, T., Koohsari, S., Yang, Y., Chen, M.-K., Matuskey, D., & Finnema, S. J. (2022) · Journal of Nuclear Medicine · doi:10.2967/jnumed.121.263201 · Cited by 104 · see citing works
Synaptic changes in psychiatric and neurological disorders: State-of-the art of in vivo imaging
Howes, O., Marcinkowska, J., Turkheimer, F. E., & Carr, R. (2025) · Neuropsychopharmacology · doi:10.1038/s41386-024-01943-x · Cited by 34 · see citing works
Visser, M., O’Brien, J. T., & Mak, E. (2024) · Ageing Research Reviews · doi:10.1016/j.arr.2024.102197 · Cited by 28 · see citing works
Fluid markers of synapse degeneration in synucleinopathies
Cervantes González, A., & Belbin, O. (2022) · Journal of Neural Transmission · doi:10.1007/s00702-022-02467-8 · Cited by 7 · see citing works
- Authors
- Andersen, K. B., Hansen, A. K., Damholdt, M. F., Horsager, J., Skjærbæk, C., Gottrup, H., Klit, H., Schacht, A. C., Danielsen, E. H., Brooks, D. J., & Borghammer, P.
- Affiliations
- Aarhus University Hospital (DK)
- Aarhus University (DK)
- Corresponding author
- Andersen, Katrine B.
- ORCID
- Venue
- Movement Disorders
- Publisher
- Wiley
- Published
- 2021-04-25
- Volume
- 36
- Issue
- 9
- Pages
- 2057-2065
- ISSN
- 0885-3185 (ISSN-L)
- 1531-8257
- OpenAlex
- W3158605453
- Cited by
- 84
- References
- 4
- Citations by year
- 2026: 12 · 2025: 16 · 2024: 25 · 2023: 15 · 2022: 13 · 2021: 3
- FWCI
- 6.70
- Type
- journal article
- Language
- en
- Open access
- green
- doi.org
- Licence
- Locations
- Movement Disorders (publishedVersion)
- PubMed (publishedVersion)
- Newcastle University ePrints (Newcastle Univesity)
- Funders
- Lundbeck Foundation (R276‐2018‐294)
- Topics
- Health Sciences › Medicine › Neurology › Parkinson's Disease Mechanisms and Treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Health Sciences › Medicine › Radiology, Nuclear Medicine and Imaging › Medical Imaging Techniques and Applications
- Keywords
- dementia with Lewy bodies, Parkinson's disease dementia, synaptic density, synaptic loss, [11C]UCB-J, substantia nigra, executive function, cognitive impairment, positron emission tomography
- MeSH terms
- Alzheimer Disease, Humans, Parkinson Disease, Lewy Body Disease, Positron-Emission Tomography, Cognitive Dysfunction
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review